{"canonical":"https://abierto.us/opportunities/75d30125r00065","key":"75D30125R00065","url":"https://abierto.us/opportunities/75d30125r00065","title":"Vaccines for Children","solicitation_number":"75D30125R00065","notice_type":"u","open":false,"response_deadline":"2025-01-30T18:00:00Z","first_posted":"2025-01-16","last_posted":"2025-08-21","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"CENTERS FOR DISEASE CONTROL AND PREVENTION","office":"CDC OFFICE OF ACQUISITION SERVICES","naics":"325412","psc":"6505","set_aside":null,"place_state":"GA","place_county":"13089","place_county_name":"DeKalb County","place_city":"1304000","place_city_name":"Atlanta","winner":"MERCK SHARP & DOHME LLC","award_amount":null,"publications":[{"notice_id":"f79fa6f1ec60479f881a05c40d8dd555","title":"FY25 Vaccines for Children","solicitation_number":"75D30125R00065","notice_type":"k","base_type":"k","posted":"2025-01-16","posted_at":null,"due_at":"2025-01-30T18:00:00Z","due_date":"2025-01-30","cancelled":null,"archived":null,"archive_date":"2025-02-14","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/f79fa6f1ec60479f881a05c40d8dd555/view","enriched":false,"history":[]},{"notice_id":"9ec6c03e10c848ea8718a6c6838d9e33","title":"FY25 Vaccines for Children","solicitation_number":"75D30125R00065","notice_type":"k","base_type":"k","posted":"2025-01-17","posted_at":null,"due_at":"2025-01-30T18:00:00Z","due_date":"2025-01-30","cancelled":null,"archived":null,"archive_date":"2025-02-14","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/9ec6c03e10c848ea8718a6c6838d9e33/view","enriched":false,"history":[]},{"notice_id":"cc30712f220748248369bc7368efe7a4","title":"FY25 Vaccines for Children","solicitation_number":"75D30125R00065","notice_type":"k","base_type":"k","posted":"2025-01-17","posted_at":null,"due_at":"2025-01-30T18:00:00Z","due_date":"2025-01-30","cancelled":null,"archived":null,"archive_date":"2025-02-14","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/cc30712f220748248369bc7368efe7a4/view","enriched":false,"history":[]},{"notice_id":"f2d9e485bef946efb0c581678f9998f0","title":"Vaccines for Children","solicitation_number":"75D30125D00195","notice_type":"u","base_type":"u","posted":"2025-08-21","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2025-08-29","award_number":"75D30125D00195","awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/f2d9e485bef946efb0c581678f9998f0/view","enriched":false,"history":[]}],"latest_notice_id":"f2d9e485bef946efb0c581678f9998f0","first_type":"k","notices":[{"dates":{"posted":"2025-01-16","response_deadline":{"raw":"2025-01-30T13:00:00-05:00","utc":"2025-01-30T18:00:00Z","date":"2025-01-30","time":"13:00:00","utc_offset_seconds":-18000}},"links":{"sam":"https://sam.gov/workspace/contract/opp/f79fa6f1ec60479f881a05c40d8dd555/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"FY25 Vaccines for Children","agency":{"office":{"code":"75D301","name":"CDC OFFICE OF ACQUISITION SERVICES"},"subtier":{"code":"7523","name":"CENTERS FOR DISEASE CONTROL AND PREVENTION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"30333","city":"ATLANTA","state":"GA","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-02-14","archive_type":"auto15"},"contacts":[{"name":"James Sprigler","role":"primary","email":"zbs6@cdc.gov","phone":"404.498.3879"},{"name":"David Dombeck","role":"secondary","email":"vwj8@cdc.gov","phone":"470.488.2695"}],"base_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"notice_id":"f79fa6f1ec60479f881a05c40d8dd555","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T17:45:50.850439Z","row_sha256":"1350217b682478767073e6cf4ca38b6467bb14a176b49284a2066d5fbcf53759","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T17:45:50.850439Z","first_seen_at":"2026-09-16T17:45:50.850439Z"},"description":{"text":"The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term \"manufacturer\" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term \"manufacture\" means to manufacture, import, process, or distribute a vaccine.","origin":"extract"},"notice_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"schema_version":1,"solicitation_number":"75D30125R00065","place_of_performance":{"zip":"30341","city":{"name":"Atlanta"},"state":{"code":"GA"},"country":{"code":"USA"}},"product_service_code":"6505"},{"dates":{"posted":"2025-01-17","response_deadline":{"raw":"2025-01-30T13:00:00-05:00","utc":"2025-01-30T18:00:00Z","date":"2025-01-30","time":"13:00:00","utc_offset_seconds":-18000}},"links":{"sam":"https://sam.gov/workspace/contract/opp/9ec6c03e10c848ea8718a6c6838d9e33/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"FY25 Vaccines for Children","agency":{"office":{"code":"75D301","name":"CDC OFFICE OF ACQUISITION SERVICES"},"subtier":{"code":"7523","name":"CENTERS FOR DISEASE CONTROL AND PREVENTION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"30333","city":"ATLANTA","state":"GA","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-02-14","archive_type":"auto15"},"contacts":[{"name":"James Sprigler","role":"primary","email":"zbs6@cdc.gov","phone":"404.498.3879"},{"name":"David Dombeck","role":"secondary","email":"vwj8@cdc.gov","phone":"470.488.2695"}],"base_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"notice_id":"9ec6c03e10c848ea8718a6c6838d9e33","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T17:45:50.850439Z","row_sha256":"9a46f301c38afa1955a16b0c922a8696480e86b838d2069a1c6bdba0291c2d28","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T17:45:50.850439Z","first_seen_at":"2026-09-16T17:45:50.850439Z"},"description":{"text":"The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term \"manufacturer\" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term \"manufacture\" means to manufacture, import, process, or distribute a vaccine.","origin":"extract"},"notice_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"schema_version":1,"solicitation_number":"75D30125R00065","place_of_performance":{"zip":"30341","city":{"name":"Atlanta"},"state":{"code":"GA"},"country":{"code":"USA"}},"product_service_code":"6505"},{"dates":{"posted":"2025-01-17","response_deadline":{"raw":"2025-01-30T13:00:00-05:00","utc":"2025-01-30T18:00:00Z","date":"2025-01-30","time":"13:00:00","utc_offset_seconds":-18000}},"links":{"sam":"https://sam.gov/workspace/contract/opp/cc30712f220748248369bc7368efe7a4/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"FY25 Vaccines for Children","agency":{"office":{"code":"75D301","name":"CDC OFFICE OF ACQUISITION SERVICES"},"subtier":{"code":"7523","name":"CENTERS FOR DISEASE CONTROL AND PREVENTION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"30333","city":"ATLANTA","state":"GA","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-02-14","archive_type":"auto15"},"contacts":[{"name":"James Sprigler","role":"primary","email":"zbs6@cdc.gov","phone":"404.498.3879"},{"name":"David Dombeck","role":"secondary","email":"vwj8@cdc.gov","phone":"470.488.2695"}],"base_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"notice_id":"cc30712f220748248369bc7368efe7a4","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T17:45:50.850439Z","row_sha256":"81a772c55f8dd18123bb0bba8bc25a60c24e68400afc5bfb4094965ef9b9c699","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T17:45:50.850439Z","first_seen_at":"2026-09-16T17:45:50.850439Z"},"description":{"text":"The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term \"manufacturer\" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term \"manufacture\" means to manufacture, import, process, or distribute a vaccine.","origin":"extract"},"notice_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"schema_version":1,"solicitation_number":"75D30125R00065","place_of_performance":{"zip":"30341","city":{"name":"Atlanta"},"state":{"code":"GA"},"country":{"code":"USA"}},"product_service_code":"6505"},{"award":{"date":"2025-04-01","number":"75D30125D00195"},"dates":{"posted":"2025-08-21","award_date":"2025-04-01"},"links":{"sam":"https://sam.gov/workspace/contract/opp/f2d9e485bef946efb0c581678f9998f0/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"Vaccines for Children","agency":{"office":{"code":"75D301","name":"CDC OFFICE OF ACQUISITION SERVICES"},"subtier":{"code":"7523","name":"CENTERS FOR DISEASE CONTROL AND PREVENTION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"30333","city":"ATLANTA","state":"GA","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-08-29","archive_type":"auto_custom"},"contacts":[{"name":"James Sprigler","role":"primary","email":"zbs6@cdc.gov"},{"name":"Chad Turner","role":"secondary","email":"ukr9@cdc.gov"}],"base_type":{"code":"u","label":"Justification"},"notice_id":"f2d9e485bef946efb0c581678f9998f0","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T17:45:50.850439Z","row_sha256":"038a1450e7421b483460ff5be437b4e76aa0ea0c49f83f50e3bb9291b76a10e5","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T17:45:50.850439Z","first_seen_at":"2026-09-16T17:45:50.850439Z"},"description":{"text":"CDC Office of Acquisition Services awarded multiple indefinite delivery, indefinite quantity (IDIQ) contracts for the National Center for Immunization and Respiratory Diseases (NCIRD) for the purchase of standard commercial pediatric & adult vaccines, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration (FDA). The vaccines awarded under these contracts will be purchased for NCIRD’s immunization awardees (the fifty state health departments, several large city program and current and former U.S. Territories) to support immunization programs as provided under Section 317(j) of the Public Health Service Act and VFC, as established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993. The initial pediatric contracts, awarded in April 2025 were established to support public sector ACIP recommended routine vaccinations for children. Merck’s pediatric contract will be modified to support purchase of Clesrovimab (Enflonsia), which is indicated for the prevention of RSV lower respiratory tract disease, hospitalization, and death in neonates and infants who are born during or entering their first RSV season, in light of the ACIP approval and accompanying VFC resolution on June 25, 2025. Clesrovimab from Merck is the second product currently licensed for the prevention of RSV in neonates and infants to prevent severe RSV disease. CDC’s current pediatric contract with Merck will be modified to include ~750,000 doses required to support purchase of Clesrovimab to administer to VFC eligible neonates and newborns. CDC intends on awarding a sole source follow on action to Merck to allow for the addition of Clesrovimab. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.","origin":"extract"},"notice_type":{"code":"u","label":"Justification"},"schema_version":1,"solicitation_number":"75D30125D00195","place_of_performance":{"city":{"name":"Atlanta"},"state":{"code":"GA"},"country":{"code":"USA"}},"product_service_code":"6505"}],"due_at":"2025-01-30T18:00:00Z","due_date":"2025-01-30","closes_at":"2025-01-30T18:00:00Z","awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7523","sub_name":"CENTERS FOR DISEASE CONTROL AND PREVENTION","office_key":"o-75D301","office_name":"CDC OFFICE OF ACQUISITION SERVICES","state":"GA","county":"13089","county_name":"DeKalb County","city":"1304000","city_name":"Atlanta","country":"USA","winner_key":"FCFDA78HKKG2","amount":null,"linked_awards":16,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"f2d9e485bef946efb0c581678f9998f0","description":{"text":"CDC Office of Acquisition Services awarded multiple indefinite delivery, indefinite quantity (IDIQ) contracts for the National Center for Immunization and Respiratory Diseases (NCIRD) for the purchase of standard commercial pediatric & adult vaccines, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration (FDA). The vaccines awarded under these contracts will be purchased for NCIRD’s immunization awardees (the fifty state health departments, several large city program and current and former U.S. Territories) to support immunization programs as provided under Section 317(j) of the Public Health Service Act and VFC, as established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993. The initial pediatric contracts, awarded in April 2025 were established to support public sector ACIP recommended routine vaccinations for children. Merck’s pediatric contract will be modified to support purchase of Clesrovimab (Enflonsia), which is indicated for the prevention of RSV lower respiratory tract disease, hospitalization, and death in neonates and infants who are born during or entering their first RSV season, in light of the ACIP approval and accompanying VFC resolution on June 25, 2025. Clesrovimab from Merck is the second product currently licensed for the prevention of RSV in neonates and infants to prevent severe RSV disease. CDC’s current pediatric contract with Merck will be modified to include ~750,000 doses required to support purchase of Clesrovimab to administer to VFC eligible neonates and newborns. CDC intends on awarding a sole source follow on action to Merck to allow for the addition of Clesrovimab. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.","html":null,"origin":"extract"},"contacts":[{"name":"James Sprigler","role":"primary","email":"zbs6@cdc.gov"},{"name":"Chad Turner","role":"secondary","email":"ukr9@cdc.gov"}],"place_of_performance":{"city":{"name":"Atlanta"},"state":{"code":"GA"},"country":{"code":"USA"}},"office_address":{"zip":"30333","city":"ATLANTA","state":"GA","country":"USA"},"naics_codes":["325412"],"award":{"date":"2025-04-01","number":"75D30125D00195"},"attachments":[],"awards":[{"award_key":"CONT_IDV_75D30125D00194_7523","permalink":"https://www.usaspending.gov/award/CONT_IDV_75D30125D00194_7523/","piid":"75D30125D00194","parent_piid":null,"award_type":null,"vendor_key":"MHBQULRMEEJ5","recipient_name":"PFIZER INC","recipient_uei":"MHBQULRMEEJ5","recipient_cage":"86491","recipient_city":"NEW YORK","recipient_state":"NY","sub_name":"Centers for Disease Control and Prevention","office_name":"CDC OFFICE OF ACQUISITION SERVICES","office_key":"o-75D301","first_action_date":"2025-03-25","last_action_date":"2026-06-29","actions":7,"obligated":"1123734611.80","current_total_value":null,"potential_total_value":"2007801000.55","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":5,"description":"END OF PWS","method":"solicitation","confidence":"high","evidence":["solicitation number 75D30125R00065 equals the FPDS solicitation identifier","same awarding office 75D301"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75D30125D00195_7523","permalink":"https://www.usaspending.gov/award/CONT_IDV_75D30125D00195_7523/","piid":"75D30125D00195","parent_piid":null,"award_type":null,"vendor_key":"FCFDA78HKKG2","recipient_name":"MERCK SHARP & DOHME LLC","recipient_uei":"FCFDA78HKKG2","recipient_cage":"6B2S4","recipient_city":"RAHWAY","recipient_state":"NJ","sub_name":"Centers for Disease Control and Prevention","office_name":"CDC OFFICE OF ACQUISITION SERVICES","office_key":"o-75D301","first_action_date":"2025-03-24","last_action_date":"2026-07-31","actions":10,"obligated":"2407704840.05","current_total_value":null,"potential_total_value":"4382496700.00","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":5,"description":"VACCINES FOR CHILDREN FY25","method":"piid","confidence":"high","evidence":["award number 75D30125D00195 equals the contract number","same awarding office 75D301"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75D30125D00196_7523","permalink":"https://www.usaspending.gov/award/CONT_IDV_75D30125D00196_7523/","piid":"75D30125D00196","parent_piid":null,"award_type":null,"vendor_key":"NCXBGGQ8YTU9","recipient_name":"SANOFI VACCINES US INC.","recipient_uei":"NCXBGGQ8YTU9","recipient_cage":"7V915","recipient_city":"SWIFTWATER","recipient_state":"PA","sub_name":"Centers for Disease Control and Prevention","office_name":"CDC OFFICE OF ACQUISITION SERVICES","office_key":"o-75D301","first_action_date":"2025-03-24","last_action_date":"2026-07-09","actions":7,"obligated":"964721458.19","current_total_value":null,"potential_total_value":"2196049020.00","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":5,"description":"VACCINES FOR CHILDREN FY25","method":"solicitation","confidence":"high","evidence":["solicitation number 75D30125R00065 equals the FPDS solicitation identifier","same awarding office 75D301"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75D30125D00197_7523","permalink":"https://www.usaspending.gov/award/CONT_IDV_75D30125D00197_7523/","piid":"75D30125D00197","parent_piid":null,"award_type":null,"vendor_key":"LA6TFGKSSFC1","recipient_name":"BAVARIAN NORDIC, INC.","recipient_uei":"LA6TFGKSSFC1","recipient_cage":"7V2J4","recipient_city":"DURHAM","recipient_state":"NC","sub_name":"Centers for Disease Control and Prevention","office_name":"CDC OFFICE OF ACQUISITION SERVICES","office_key":"o-75D301","first_action_date":"2025-03-24","last_action_date":"2026-07-20","actions":4,"obligated":"527850.00","current_total_value":null,"potential_total_value":"12622500.00","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":5,"description":"VACCINES FOR CHILDREN FY25","method":"solicitation","confidence":"high","evidence":["solicitation number 75D30125R00065 equals the FPDS solicitation identifier","same awarding office 75D301"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75D30125D00198_7523","permalink":"https://www.usaspending.gov/award/CONT_IDV_75D30125D00198_7523/","piid":"75D30125D00198","parent_piid":null,"award_type":null,"vendor_key":"FRHTPHMZMX47","recipient_name":"GLAXOSMITHKLINE, LLC","recipient_uei":"FRHTPHMZMX47","recipient_cage":"667E9","recipient_city":"DURHAM","recipient_state":"NC","sub_name":"Centers for Disease Control and Prevention","office_name":"CDC OFFICE OF ACQUISITION SERVICES","office_key":"o-75D301","first_action_date":"2025-03-24","last_action_date":"2026-07-14","actions":8,"obligated":"793016569.64","current_total_value":null,"potential_total_value":"928389595.14","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":5,"description":"VACCINES FOR CHILDREN FY25","method":"solicitation","confidence":"high","evidence":["solicitation number 75D30125R00065 equals the FPDS solicitation identifier","same awarding office 75D301"],"opportunity_key":null,"opportunity_title":null}],"related":[{"key":"75D30126Q79289","latest_notice_id":"c444d1799dfc4555956898d2e081aee5","title":"Flyability Elios 3 Surveying LiDAR Drone","solicitation_number":"75D301-26-Q-79289","notice_type":"o","first_type":"o","first_posted":"2026-09-14","last_posted":"2026-09-14","notices":1,"due_at":"2026-09-18T14:00:00Z","due_date":"2026-09-18","closes_at":"2026-09-18T14:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7523","sub_name":"CENTERS FOR DISEASE CONTROL AND PREVENTION","office_key":"o-75D301","office_name":"CDC OFFICE OF ACQUISITION SERVICES","naics":"336411","psc":"1550","set_aside":null,"state":"PA","county":"42003","county_name":"Allegheny County","city":"4261000","city_name":"Pittsburgh","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"75D30126Q79261","latest_notice_id":"656f1488568a4ed5a379c84545d8d15e","title":"Systematic Information Review","solicitation_number":"75D301-26-Q-79261","notice_type":"k","first_type":"k","first_posted":"2026-09-02","last_posted":"2026-09-14","notices":2,"due_at":"2026-09-18T16:00:00Z","due_date":"2026-09-18","closes_at":"2026-09-18T16:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7523","sub_name":"CENTERS FOR DISEASE CONTROL AND PREVENTION","office_key":"o-75D301","office_name":"CDC OFFICE OF ACQUISITION SERVICES","naics":"541990","psc":"R499","set_aside":"SBA","state":"GA","county":"13089","county_name":"DeKalb County","city":"1304000","city_name":"Atlanta","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-17T06:28:38.602097Z"},{"key":"75D30126R73515","latest_notice_id":"c40e701a3cd34dd79eb068b421d1c461","title":"Electronic Key Box System","solicitation_number":"75D301-26-R-73515","notice_type":"o","first_type":"o","first_posted":"2026-09-03","last_posted":"2026-09-03","notices":1,"due_at":"2026-09-18T16:00:00Z","due_date":"2026-09-18","closes_at":"2026-09-18T16:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7523","sub_name":"CENTERS FOR DISEASE CONTROL AND PREVENTION","office_key":"o-75D301","office_name":"CDC OFFICE OF ACQUISITION SERVICES","naics":"561621","psc":"N066","set_aside":"SBA","state":"GA","county":"13089","county_name":"DeKalb County","city":null,"city_name":null,"country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"202695987","latest_notice_id":"a777b0e867174da0a855e8ed547719c9","title":"Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement","solicitation_number":"2026-95987","notice_type":"p","first_type":"p","first_posted":"2025-12-09","last_posted":"2025-12-09","notices":1,"due_at":"2026-12-24T21:00:00Z","due_date":"2026-12-24","closes_at":"2026-12-24T21:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7523","sub_name":"CENTERS FOR DISEASE CONTROL AND PREVENTION","office_key":"o-75D301","office_name":"CDC OFFICE OF ACQUISITION SERVICES","naics":"811210","psc":"J066","set_aside":null,"state":"GA","county":"13089","county_name":"DeKalb County","city":null,"city_name":null,"country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"}]}